Testing Challenges: Evaluation of Novel Diagnostics and Molecular Biomarkers

Overview

Journal Clin Med (Lond)

Specialty General Medicine

Date 2009 Mar 11

PMID 19271607

Citations 9

Authors

Ronald L Zimmern

Affiliations

Soon will be listed here.

Abstract

Through the lens of public health genomics, this article probes certain issues that concern the evaluation of diagnostic tests and molecular biomarkers, and the accompanying policy and regulatory implications. It begins with some conceptual remarks followed by a discussion of evaluation, translation, and regulation, and their importance for public health.

Citing Articles

A Systematic Review and Recommendations Around Frameworks for Evaluating Scientific Validity in Nutritional Genomics.

Keathley J, Garneau V, Zavala-Mora D, Heister R, Gauthier E, Morin-Bernier J Front Nutr. 2022; 8:789215.

PMID: 35004815 PMC: 8728558. DOI: 10.3389/fnut.2021.789215.

Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.

Horgan D, Ciliberto G, Conte P, Baldwin D, Seijo L, Montuenga L Biomed Hub. 2021; 5(3):182-223.

PMID: 33564664 PMC: 7841733. DOI: 10.1159/000511209.

Cardiac biomarkers of acute coronary syndrome: from history to high-sensitive cardiac troponin.

Plebani M, Antonelli G, Zaninotto M Intern Emerg Med. 2017; 12(2):143-145.

PMID: 28210831 DOI: 10.1007/s11739-017-1613-0.

Making Alzheimer's and dementia research fit for populations.

Brayne C, Davis D Lancet. 2012; 380(9851):1441-3.

PMID: 23084456 PMC: 3974586. DOI: 10.1016/S0140-6736(12)61803-0.

Next-generation sequencing in the clinic: are we ready?.

Biesecker L, Burke W, Kohane I, Plon S, Zimmern R Nat Rev Genet. 2012; 13(11):818-24.

PMID: 23076269 PMC: 3891793. DOI: 10.1038/nrg3357.

References

Zimmern R, Kroese M . The evaluation of genetic tests. J Public Health (Oxf). 2007; 29(3):246-50. DOI: 10.1093/pubmed/fdm028. View

Melzer D, Hogarth S, Liddell K, Ling T, Sanderson S, Zimmern R . Genetic tests for common diseases: new insights, old concerns. BMJ. 2008; 336(7644):590-3. PMC: 2267938. DOI: 10.1136/bmj.39506.601053.BE. View

Lomas J . The in-between world of knowledge brokering. BMJ. 2007; 334(7585):129-32. PMC: 1779881. DOI: 10.1136/bmj.39038.593380.AE. View

Pepe M, Janes H, Longton G, Leisenring W, Newcomb P . Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol. 2004; 159(9):882-90. DOI: 10.1093/aje/kwh101. View

Pharoah P, Antoniou A, Easton D, Ponder B . Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med. 2008; 358(26):2796-803. DOI: 10.1056/NEJMsa0708739. View

Burke W, Zimmern R . Ensuring the appropriate use of genetic tests. Nat Rev Genet. 2004; 5(12):955-9. DOI: 10.1038/nrg1495. View

Groves C, Zeggini E, Minton J, Frayling T, Weedon M, Rayner N . Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes. 2006; 55(9):2640-4. DOI: 10.2337/db06-0355. View

Holtzman N, Marteau T . Will genetics revolutionize medicine?. N Engl J Med. 2000; 343(2):141-4. DOI: 10.1056/NEJM200007133430213. View

Lenfant C . Shattuck lecture--clinical research to clinical practice--lost in translation?. N Engl J Med. 2003; 349(9):868-74. DOI: 10.1056/NEJMsa035507. View

10.

Janssens A, Gwinn M, Bradley L, Oostra B, Van Duijn C, Khoury M . A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet. 2008; 82(3):593-9. PMC: 2427295. DOI: 10.1016/j.ajhg.2007.12.020. View

11.

Zerhouni E . Translational and clinical science--time for a new vision. N Engl J Med. 2005; 353(15):1621-3. DOI: 10.1056/NEJMsb053723. View

12.

Kroese M, Zimmern R, Sanderson S . Genetic tests and their evaluation: can we answer the key questions?. Genet Med. 2004; 6(6):475-80. DOI: 10.1097/01.gim.0000144060.84960.36. View

13.

Zheng S, Sun J, Wiklund F, Smith S, Stattin P, Li G . Cumulative association of five genetic variants with prostate cancer. N Engl J Med. 2008; 358(9):910-9. DOI: 10.1056/NEJMoa075819. View